in 2002 that 29% of bipolar patients and 35% of general practice patients approve of prenatal testing for bipolar susceptibility genes (Jones et al., 2002). Meiser et al. (2008), working in Australia, found more support, reporting that 54% of bipolar patients and 55% of unaffected family members were interested in prenatal testing for bipolar disorder. Considering schizophrenia specifically, DeLisi and Bertisch (2006) reported that 56% of unaffected family members, 56% of clinical psychiatrists, and 25% of psychiatric genetic researchers supported prenatal testing (chi-square, p<0.001).
